ASTHMA; EOSINOPHILIC
Clinical trials for ASTHMA; EOSINOPHILIC explained in plain language.
Never miss a new study
Get alerted when new ASTHMA; EOSINOPHILIC trials appear
Sign up with your email to follow new studies for ASTHMA; EOSINOPHILIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug shows promise for Hard-to-Control asthma
Disease control OngoingThis study tests an oral medication called dexpramipexole for people with eosinophilic asthma that is not well controlled by current treatments. About 600 participants will take the drug or a placebo daily for 24 weeks to see if it improves lung function, asthma control, and qual…
Matched conditions: ASTHMA; EOSINOPHILIC
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
BREATHING EASIER, MOVING MORE: ASTHMA DRUG MAY BOOST ACTIVITY
Symptom relief OngoingThis study looks at whether mepolizumab, a drug already used to reduce asthma attacks, can also help people with severe asthma become more physically active. About 62 adults with severe eosinophilic asthma will have their daily steps and exercise tolerance measured before and aft…
Matched conditions: ASTHMA; EOSINOPHILIC
Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated May 17, 2026 13:45 UTC